Gps Wealth Strategies Group, LLC Vertex Pharmaceuticals Inc Transaction History
Gps Wealth Strategies Group, LLC
- $881 Million
- Q3 2025
A detailed history of Gps Wealth Strategies Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 896 shares of VRTX stock, worth $388,881. This represents 0.04% of its overall portfolio holdings.
Number of Shares
896
Previous 1,059
15.39%
Holding current value
$388,881
Previous $471,000
25.69%
% of portfolio
0.04%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding VRTX
# of Institutions
1,791Shares Held
231MCall Options Held
1.84MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...